New combo therapy for advanced cancers enters real-world trial
Disease control
Not yet recruiting
This study will observe 300 people with advanced solid tumors (like lung or gastrointestinal cancers) who receive adebrelimab combined with other treatments. The goal is to see how safe and effective these combinations are in everyday medical practice. Researchers will track side…
Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated May 06, 2026 16:01 UTC